The Asia-Pacific Nanotechnology in Medical Device Market is believed to be a USD 1211 Million market in 2018 and is anticipated to reach USD 2346 Million by the end of 2021 with a tremendous CAGR of 14.1% in the forecasted period. The significant growth of the market since last decade is attributed to the technology evolution, increasing aging population and incidences of diseases. The nanotechnology in medicine is trusted to have a greater impact in the treatment, diagnosis and prevention of diseases.
Nanotechnology in the medical devices deals with the repair at cellular level having dimensions that are minute fractions of a human hair. Many applications of nanotechnology are in pipeline undergoing testing at various stages offering exciting opportunities. Nanotechnology is in its way of revolutionising the way of treatment having the potentiality to save many lives in the future.
The nanotechnology based medical devices market is driven by a host of factors that include increasing funding from government and rising facilities in research and development of nanotechnology, increasing prevalence of aging population, rising awareness among the people, growing healthcare expenditure with the rising availability of insurance coverage and reimbursement. However, the market also face a few restraints that are effecting the growth which include stringent regulatory policies and high costs involving the nanotechnology in medical devices.
The Asia-Pacific nanotechnology based medical device market is categorised based on the type of the product as implantable material, biochips, active implantable material, medical textile and wound dressing and others. The implantable material includes dental filling material and bone restorative material. The active implantable materials is further categorised as rental implants, hearing aid devices and cardio rhythm management. By application the nanotechnology market’s segmentation is as research, diagnostics and therapeutics applications. Based on geography, the regions in Asia-Pacific is segmented as China, India, Japan, South Korea and Australia.
The major companies in the industry includes 3M Company, Acusphere, Inc., Affymetrix, Inc., AMAG Pharmaceuticals, Starkey Hearing Technologies, PerkinElmer, Inc., Smith & Nephew, Inc., Stryker Corporation and Jude Medical, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Product
5.1.1 Implantable Material
5.1.1.1 Bone Restorative Material
5.1.1.2 Dental Filling Material
5.1.2active implantable material
5.1.2.1 Hearing Aid Devices
5.1.2.2 Cardio Rhythm Management Devices
5.1.3 Biochips
5.1.4 Medical Textile and Wound Dressing
5.1.5 Others
5.2 By Application
5.2.1 Diagnostics
5.2.2 Therapeutics
5.2.3 Research
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Acusphere, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AMAG Pharmaceuticals
8.3 Stryker Corporation
8.4 3M Company
8.5 St. Jude Medical, Inc.
8.6 Affymetrix, Inc.
8.7 Smith & Nephew, Inc.
8.8 PerkinElmer, Inc.
8.9 Starkey Hearing Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
